Genetic variation in the two-pore domain potassium channel, TASK-1, may contribute to an atrial substrate for arrhythmogenesis
- PMID: 24374141
- DOI: 10.1016/j.yjmcc.2013.12.014
Genetic variation in the two-pore domain potassium channel, TASK-1, may contribute to an atrial substrate for arrhythmogenesis
Abstract
The two-pore domain potassium channel, K2P3.1 (TASK-1) modulates background conductance in isolated human atrial cardiomyocytes and has been proposed as a potential drug target for atrial fibrillation (AF). TASK-1 knockout mice have a predominantly ventricular phenotype however, and effects of TASK-1 inactivation on atrial structure and function have yet to be demonstrated in vivo. The extent to which genetic variation in KCNK3, that encodes TASK-1, might be a determinant of susceptibility to AF is also unknown. To address these questions, we first evaluated the effects of transient knockdown of the zebrafish kcnk3a and kcnk3b genes and cardiac phenotypes were evaluated using videomicroscopy. Combined kcnk3a and kcnk3b knockdown in 72 hour post fertilization embryos resulted in lower heart rate (p<0.001), marked increase in atrial diameter (p<0.001), and mild increase in end-diastolic ventricular diameter (p=0.01) when compared with control-injected embryos. We next performed genetic screening of KCNK3 in two independent AF cohorts (373 subjects) and identified three novel KCNK3 variants. Two of these variants, present in one proband with familial AF, were located at adjacent nucleotides in the Kozak sequence and reduced expression of an engineered reporter. A third missense variant, V123L, in a patient with lone AF, reduced resting membrane potential and altered pH sensitivity in patch-clamp experiments, with structural modeling predicting instability in the vicinity of the TASK-1 pore. These in vitro data suggest that the double Kozak variants and V123L will have loss-of-function effects on ITASK. Cardiac action potential modeling predicted that reduced ITASK prolongs atrial action potential duration, and that this is potentiated by reciprocal changes in activity of other ion channel currents. Our findings demonstrate the functional importance of ITASK in the atrium and suggest that inactivation of TASK-1 may have diverse effects on atrial size and electrophysiological properties that can contribute to an arrhythmogenic substrate.
Keywords: AF; APD; Atrial action potential duration; Atrial fibrillation; BCL; CHO; Chinese hamster ovary; ERP; HRV; K(2)(P); SNP; TASK-1; Two-pore domain potassium channels; WT; action potential duration; atrial fibrillation; basic cycle length; effective refractory period; heart rate variability; hours post fertilization; hpf; single nucleotide polymorphisms; two-pore domain K(+) channels; wild-type.
Copyright © 2013 Elsevier Ltd. All rights reserved.
Similar articles
-
Atrial fibrillation and heart failure-associated remodeling of two-pore-domain potassium (K2P) channels in murine disease models: focus on TASK-1.Basic Res Cardiol. 2018 Jun 7;113(4):27. doi: 10.1007/s00395-018-0687-9. Basic Res Cardiol. 2018. PMID: 29881975
-
The two-pore domain potassium channel, TWIK-1, has a role in the regulation of heart rate and atrial size.J Mol Cell Cardiol. 2016 Aug;97:24-35. doi: 10.1016/j.yjmcc.2016.04.006. Epub 2016 Apr 19. J Mol Cell Cardiol. 2016. PMID: 27103460
-
Genetic Ablation of TASK-1 (Tandem of P Domains in a Weak Inward Rectifying K+ Channel-Related Acid-Sensitive K+ Channel-1) (K2P3.1) K+ Channels Suppresses Atrial Fibrillation and Prevents Electrical Remodeling.Circ Arrhythm Electrophysiol. 2019 Sep;12(9):e007465. doi: 10.1161/CIRCEP.119.007465. Epub 2019 Sep 13. Circ Arrhythm Electrophysiol. 2019. PMID: 31514528
-
[Cardiac two-pore-domain potassium channels (K2P): Physiology, pharmacology, and therapeutic potential].Dtsch Med Wochenschr. 2012 Aug;137(33):1654-8. doi: 10.1055/s-0032-1305216. Epub 2012 Aug 8. Dtsch Med Wochenschr. 2012. PMID: 22875694 Review. German.
-
Inhibition of cardiac two-pore-domain K+ (K2P) channels--an emerging antiarrhythmic concept.Eur J Pharmacol. 2014 Sep 5;738:250-5. doi: 10.1016/j.ejphar.2014.05.056. Epub 2014 Jun 10. Eur J Pharmacol. 2014. PMID: 24927994 Review.
Cited by
-
Basic Research Approaches to Evaluate Cardiac Arrhythmia in Heart Failure and Beyond.Front Physiol. 2022 Feb 7;13:806366. doi: 10.3389/fphys.2022.806366. eCollection 2022. Front Physiol. 2022. PMID: 35197863 Free PMC article. Review.
-
The versatile regulation of K2P channels by polyanionic lipids of the phosphoinositide and fatty acid metabolism.J Gen Physiol. 2022 Feb 7;154(2):e202112989. doi: 10.1085/jgp.202112989. Epub 2021 Dec 20. J Gen Physiol. 2022. PMID: 34928298 Free PMC article.
-
PITX2 Modulates Atrial Membrane Potential and the Antiarrhythmic Effects of Sodium-Channel Blockers.J Am Coll Cardiol. 2016 Oct 25;68(17):1881-1894. doi: 10.1016/j.jacc.2016.07.766. J Am Coll Cardiol. 2016. PMID: 27765191 Free PMC article.
-
Single-Cell Resolution of Temporal Gene Expression during Heart Development.Dev Cell. 2016 Nov 21;39(4):480-490. doi: 10.1016/j.devcel.2016.10.001. Epub 2016 Nov 10. Dev Cell. 2016. PMID: 27840107 Free PMC article.
-
Breathing Stimulant Compounds Inhibit TASK-3 Potassium Channel Function Likely by Binding at a Common Site in the Channel Pore.Mol Pharmacol. 2015 Nov;88(5):926-34. doi: 10.1124/mol.115.100107. Epub 2015 Aug 12. Mol Pharmacol. 2015. PMID: 26268529 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
